Trulieve to Open 36th Dispensary in Destin, Florida

DESTIN, Fla. -- Trulieve Cannabis Corp. (CSE: TRUL & OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, is set to open the doors of their latest location on Tuesday, October 1st. Trulieve's newest location is the first dispensary in the community of Destin and advances the company's mission of expanding and ensuring patient access statewide.

Trulieve presently operates 35 other dispensaries throughout the State of Florida, including in the nearby communities of Pensacola and Tallahassee.

"Trulieve originally started in Florida's Panhandle, so we're especially excited to open our Destin location and bringing patients in the area direct access to the medications they've come to rely on. Our mission is to ensure patients have access to safe, reliable products and we're fulfilling that promise in Destin by opening the first dispensary in the area," said Trulieve CEO Kim Rivers.

Rivers continued, "We're looking forward to educating patients on the process, from their first steps into medical cannabis to exploring new treatment options, and offering direct access for those who may not have had convenient access to a dispensary in the past."

To celebrate their newest store, Trulieve will be hosting a grand opening celebration on Tuesday, October 1st at 10:00 AM, with doors opening and press tours of the new dispensary immediately following. In honor of the grand opening, all patients are eligible for an in-store 25% discount at the Destin location on the day of.

  • WHAT: Trulieve Destin Grand Opening
  • WHERE: 868 Highway 98 East, Destin, Florida 32541
  • WHEN: Tuesday, October 1, 2019 at 10:00 AM

In stores and online, patients will find Florida's largest selection of THC and CBD products, available in a variety of delivery methods, including smokable cannabis, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers home delivery statewide for patients, in addition to its 36 dispensaries in locations across the state from Pensacola to Key West.

As the state's leading medical cannabis provider, Trulieve's employees are knowledgeable and eager to help patients. Trulieve encourages potential patients as well as patients who are new to cannabis and our wide array of products to connect with the staff to learn more.

The Office of Medical Marijuana Use recently announced the registry was nearing 270,000 registered medical marijuana patients with an active ID card, with Trulieve consistently selling over half of the state's overall volume, per the Florida Department of Health. There are presently 2,500 registered ordering physicians in the State of Florida as well.

For more information, please visit www.Trulieve.com.

About Trulieve 

Trulieve is a vertically integrated "seed-to-sale" company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts and Connecticut. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.

This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.


Subscribe to our newsletter

The latest news, articles, and resources, sent to your inbox weekly.